OAM
BIO icon

OP Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

OP Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,104
Closed -$3.65M – 773
2026
Q1 		$3.65M Buy
13,104
+10,446
+393% +$3.01M 0.03% 308
2025
Q4 		$805K Sell
2,658
-638
-19% -$199K 0.01% 607
2025
Q3 		$924K Buy
+3,296
New +$897K 0.01% 596
2025
Q2 		– Sell
-2,257
Closed -$550K – 794
2025
Q1 		$550K Buy
+2,257
New +$679K 0.01% 657

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

OP Asset Management's BIO Position: Q2 2026 in Review

OP Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 13,104 shares — an estimated $3.65M sold.

OP Asset Management first reported a position in BIO in Q1 2025 and held it in 4 quarters. The position peaked at $3.65M in Q1 2026. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • OP Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 13,104 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.65M.
  • OP Asset Management first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and held it in 4 quarters.
  • OP Asset Management's Bio-Rad Laboratories Class A position peaked at $3.65M in Q1 2026.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.